As of 2024-12-15, the Fair Value of Corline Biomedical AB (CLBIO.ST) is -2.24 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.28 SEK, the upside of Corline Biomedical AB is -127.07%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -9.54 | -7.29 | -6.92 | 2.33 | -1.81 | -4.65 |
| YoY growth | -40.44% | 23.62% | 5.01% | 133.65% | -177.67% | -11.17% |
| Market Cap (mil) | 177.94 |
| P/E | |
| Forward P/E |
| EPS | -0.45 |
| Avg earnings growth rate | -11.17% |
| TTM earnings | -9.63 |